Subscribe to RSS
DOI: 10.1055/s-0028-1100952
© Georg Thieme Verlag KG Stuttgart · New York
Hydrokortison auf der Intensivstation: Wer sollte behandelt werden und wann? [1]
Hydrocortisone in intensive care medicine: who should be treated and when?Publication History
eingereicht: 12.6.2008
akzeptiert: 1.9.2008
Publication Date:
19 November 2008 (online)

Schlüsselwörter
Hydrokortison - Nebennierenrindeninsuffizienz - septischer Schock - Sepsis
Keywords
hydrocortisone - adrenal insufficiency - septic shock - sepsis
1 Herrn Prof. Dr. Dr. h. c. Klaus Peter zum 70. Geburtstag gewidmet.
Literatur
- 1
Annane D, Maxime V, Ibrahim F, Alvarez J C, Abe E, Boudou P.
Diagnosis of adrenal
insufficiency in severe sepsis and septic shock.
Am J
Respir Crit Care Med.
2006;
174
1319-1326
MissingFormLabel
- 2
Annane D, Sebille V, Bellissant E. Ger-Inf-05 Study Group .
Effect of low doses of
Corticosteroids in septic shock patients with or without early acute
respiratory distress syndrome.
Crit Care Med.
2006;
34
22-30
MissingFormLabel
- 3
Annane D, Sebille V, Charpentier C. et al .
Effect of treatment with low doses of hydrocortisone
and fludrocortisone on mortality in patients with septic shock.
JAMA.
2002;
288
862-871
MissingFormLabel
- 4
Annane D, Sébille V, Troché G, Raphaël J C, Gajdos P, Bellissant E.
A 3-level prognostic classification in septic shock based on
cortisol levels and cortisol response to corticotropin.
JAMA.
2000;
283
1038-1045
MissingFormLabel
- 5
Bollaert P E, Charpentier C, Levy B. et al .
Reversal of late septic shock with supraphysiologic
doses of hydrocortisone.
Crit Care Med.
1998;
26
645-650
MissingFormLabel
- 6
Briegel J, Forst H, Haller M. et al .
Stress doses of hydrocortisone reverse
hyperdynamic septic shock: a prospective, randomized, double-blind,
singlecenter study.
Crit Care Med.
1999;
27
723-732
MissingFormLabel
- 7
Chawla K, Kupfer Y, Tessler S.
Hydrocortisone reverses refractory septic shock.
Crit Care
Med.
1999;
27
A33
MissingFormLabel
- 8
Confalonieri M, Urbino R, Potena A. et al .
Hydrocortisone infusion for severe community-acquired
pneumonia: a preliminary randomized study.
Am J Respir
Crit Care Med.
2005;
171
242-248
MissingFormLabel
- 9
Eklund A, Leppaniemi A, Kemppainen E, Pettila V.
Vasodilatory shock in
severe acute pancreatitis without sepsis: is there any place for
hydrocortisone treatment?.
Acta Anaesthesiol Scand.
2005;
49
379-384
MissingFormLabel
- 10
Halonen J, Halonen P, Järvinen O. et al .
Corticosteroids for the prevention of atrial
fibrillation after cardiac surgery. A randomized controlled trial.
JAMA.
2007;
297
1562-1567
MissingFormLabel
- 11
Hoen S, Mazoit J X, Asehnoune K. et al .
Hydrocortisone increases the sensitivity
to alpha1-adrenoceptor stimulation in humans following hemorrhagic
shock.
Crit Care Med.
2005;
33
2737-2743
MissingFormLabel
- 12
Keh D, Boehnke T, Weber-Carstens S. et al .
Immunologic and hemodynamic effects of „low
dose” hydrocortisone in septic shock: a double-blind, randomized,
placebo-controlled, crossover study.
Am J Respir Crit Care
Med.
2003;
167
512-520
MissingFormLabel
- 13
Kilger E, Weis F, Briegel J. et al .
Stress doses of hydrocortisone reduce severe
systemic inflammatory response syndrome and improve early outcome
in a risk group of patients after cardiac surgery.
Crit
Care Med.
2003;
31
1068-1074
MissingFormLabel
- 14
Lipiner-Friedmann D, Sprung C L, Laterre P F. et al, Corticus Study Group .
Adrenal
function in sepsis: The retrospective Corticus cohort study.
Crit
Care Med.
2007;
35
1012-1018
MissingFormLabel
- 15
Meduri G U, Golden E, Freire A X. et al .
Methylprednisolone infusion in early severe ARDS:
results of a randomized controlled trial.
Chest.
2007;
131
954-963
MissingFormLabel
- 16
Meduri G U, Headley A S, Golden E. et al .
Effect of prolonged methylprednisolone
therapy in unresolving acute respiratory distress syndrome: a randomized
controlled trial.
JAMA.
1998;
280
159-165
MissingFormLabel
- 17
Meduri G U, Marik P E, Chrousos G P. et al .
Steroid treatment in ARDS:
a critical appraisal of the ARDS network trial and the recent literature.
Intensive Care Med.
2008;
34
61-69
MissingFormLabel
- 18
Meduri G U, Tolley E A, Chrousos G P, Stentz F.
Prolonged
methylprednisolone treatment suppresses systemic inflammation in
patients with unresolving acute respiratory distress syndrome: evidence
for inadequate endogenous glucocorticoid secretion and inflammation-induced
immune cell resistance to glucocorticoids.
Am J Respir Crit
Care Med.
2002;
165
983-991
MissingFormLabel
- 19
Muller C A, Vogeser M, Belyaev O. et al .
Role of endogenous glucocorticoid metabolism in
human acute pancreatitis.
Crit Care Med.
2006;
34
1060-1066
MissingFormLabel
- 20
Oppert M, Reinicke A, Graf K J. et al .
Plasma cortisol levels before and during „low-dose” hydrocortisone
therapy and their relationship to hemodynamic improvement in patients
with septic shock.
Intensive Care Med.
2000;
26
1747-1755
MissingFormLabel
- 21
Oppert M, Schindler R, Husung C. et al .
Low-dose hydrocortisone improves shock
reversal and reduces cytokine levels in early hyperdynamic septic
shock.
Crit Care Med.
2005;
33
2457-2464
MissingFormLabel
- 22
Sprung C L, Annane D, Keh D. et
al, CORTICUS Study Group .
Hydrocortisone therapy for patients
with septic shock.
N Engl J Med.
2008;
358
111-124
MissingFormLabel
- 23
Steinberg K P, Hudson L D, Goodman R B. et al .
National Heart, Lung, and
Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical
Trials Network. Efficacy and safety of Corticosteroids for persistent acute
respiratory distress syndrome.
N Engl J Med.
2006;
354
1671-1684
MissingFormLabel
- 24
Weis F, Kilger E, Beiras-Fernandez A. et al .
Association between vasopressor dependence
and early outcome in patients after cardiac surgery.
Anaesthesia.
2006;
61
938-942
MissingFormLabel
1 Herrn Prof. Dr. Dr. h. c. Klaus Peter zum 70. Geburtstag gewidmet.
Dr. med. Patrick Möhnle
Klinik für Anästhesiologie der Universität
München
Marchioninistr. 15
81377 München
Phone: 089/7095-3410
Fax: 089/7095-8886
Email: patrick.moehnle@med.uni-muenchen.de